PerkinElmer Inc (PKI.N)
75.10USD
19 Apr 2018
-- (--)
$75.10
--
--
--
--
191,668
$84.42
$56.22
About
Overall
Beta: | 0.83 |
Market Cap(Mil.): | $8,442.53 |
Shares Outstanding(Mil.): | 110.50 |
Dividend: | 0.07 |
Yield (%): | 0.37 |
Financials
PKI.N | Industry | Sector | |
---|---|---|---|
P/E (TTM): | 31.53 | 33.54 | 33.25 |
EPS (TTM): | 2.38 | -- | -- |
ROI: | 5.98 | 9.93 | 13.13 |
ROE: | 11.31 | 14.73 | 14.96 |
BRIEF-PerkinElmer Appoints James Mock As Chief Financial Officer
* PERKINELMER INC - ANDY WILSON WILL REMAIN WITH COMPANY AS AN ADVISOR FOR AN INTERIM PERIOD Source text for Eikon: Further company coverage:
BRIEF-PerkinElmer Collaborates With Helix In Exome Based Personal Genomics
* PERKINELMER COLLABORATES WITH HELIX TO DRIVE INNOVATION IN EXOME-BASED PERSONAL GENOMICS
BRIEF-Perkinelmer Inc Files Prospectus Supplement Related To A Potential Senior Notes Offering
* PERKINELMER INC FILES PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL SENIOR NOTES OFFERING - SEC FILING Source text: (https://bit.ly/2q3PNq6) Further company coverage:
BRIEF-RHS Enters Deal For Perkinelmer, Inc To Buy All Shares Of Co For $0.28 Per Share
* ENTERS SCHEME IMPLEMENTATION AGREEMENT FOR PERKINELMER, INC TO BUY ALL SHARES OF CO FOR $0.28 PER SHARE
BRIEF-Perkinelmer Reports Q4 GAAP Loss Per Share From Cont Ops of $0.35
* Q4 ADJUSTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS $0.97
PerkinElmer profit, 2018 forecast top Wall Street estimates
Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.
UPDATE 1-PerkinElmer profit, 2018 forecast top Wall Street estimates
Jan 25 Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.
PerkinElmer profit, 2018 forecast top Wall Street estimates
Jan 25 Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.
BRIEF-Perkinelmer Q4 Adjusted Earnings Per Share $0.97 From Continuing Operations
* PERKINELMER ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2017
BRIEF-Perkinelmer Inc reports Q3 adjusted earnings per share $0.73
* Perkinelmer Inc announces financial results for the third quarter of 2017
Competitors
Price | Chg | |
---|---|---|
Thermo Fisher Scientific Inc. (TMO.N) | $216.99 | -- |
Agilent Technologies Inc (A.N) | $67.97 | -- |
Waters Corporation (WAT.N) | $207.39 | -- |